Mercury Laboratories Ltd. (MERCURYLAB)
Market Closed
7 Aug, 22:00
MSE MSE Primary ₹
818. 90
0
0%
₹
973.2M Market Cap
33.85 P/E Ratio
7% Div Yield
4 Volume
0 Eps
₹ 818.9
Previous Close Want to track MERCURYLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MERCURYLAB closed Friday higher at ₹818.9, an increase of 0% from Thursday's close, completing a monthly decrease of -1.6927% or -₹14.1. Over the past 12 months, MERCURYLAB stock gained 1.4746%.
MERCURYLAB pays dividends to its shareholders, with the most recent payment made on Sep 11, 2025. The next estimated payment will be in In 1 month on Sep 11, 2026 for a total of ₹3.5.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 7.3356%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
MERCURYLAB Chart
People also search for
Mercury Laboratories Ltd. (MERCURYLAB) FAQ
What is the stock price today?
The current price is ₹818.90.
On which exchange is it traded?
Mercury Laboratories Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is MERCURYLAB.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 7%.
What is its market cap?
As of today, the market cap is 973.2M.
Has Mercury Laboratories Ltd. ever had a stock split?
No, there has never been a stock split.
Mercury Laboratories Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Rajendra Ramanlal Shah CEO | MSE Exchange | INE947G01011 ISIN |
| India Country | 503 Employees | 6 Aug 2025 Last Dividend | - Last Split | - IPO Date |
Mercury Laboratories Ltd. is an established pharmaceutical company focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. Primarily serving the healthcare sector, Mercury Laboratories Ltd. offers an extensive catalog that includes antibiotics, antiviral drugs, analgesics, and other therapeutic formulations targeting a variety of medical needs. The company's robust product line is supplied to healthcare providers, hospitals, and pharmacies, contributing significantly to the medical and pharmaceutical industries. Mercury Laboratories Ltd. plays a crucial role in addressing healthcare demands with quality and affordable medications, supported by their commitment to research and development. Furthermore, the company's reach extends across both domestic and international markets, underlining its importance in the global pharmaceutical landscape. With its focus on innovation and quality compliance, Mercury Laboratories Ltd. remains a key player in enhancing public health and medical treatment accessibility.
Contact Information
Address: 2/13-14, BIDC Gorwa Industrial Estate
Phone: 91 26 5247 7900
Website: https://www.mercurylabs.com
